Dialysa, LLC was founded in 2007 to provide analytical services (LAL and Plate Count Analysis) as well as Chemistry support for Dialysis facilities in accordance AAMI (The Association for the Advancement of Medical Instrumentation) protocol. The Limulus Amebocyte Lysate (LAL) test is based on quantitative kinetic assay for the detection of Gram-negative bacterial endotoxin. The Heterotrophic Plate Count (HPC) test is formerly known as a standard plate count and is used for estimating the number of live heterotrophic bacteria. in water samples Our competent professionals have decades of experience in routine microbiological analysis, special microbiology, research microbiology, and a variety of other microbiological testing
Advisor in Chief For many years, Mr. Krasnyansky has been a teacher, strategic planner and mentor. He is an entrepreneur who goes through life creating businesses, nurturing people and managing effectively. He enjoys multi-tasking, his startup and management expertise ranges from environmental companies to computer ventures. He is an expert in Marketing and Business Development. With over 25 years of experience in the founding, acquisition and sale of profitable companies, has been instrumental in providing turn around and financial expertise to companies worldwide. Michael wrote of over 20 articles, patents, and books throughout his career. Experience working with Federal, State agencies: EPA, FDA, DOD.
Ms. Lilia Shtarkman has over 25 years of testing laboratory and chemical industry experience as a chemist, QA/AC officer, Vice President of Operation and President of Environmental Company. Before founding Dilaysa, LLC Mrs. Shtarkman was a Vice President of Operations at American Testing Company, Inc. Previously Mrs. Shtarkman was a President and CEO of EnviroTest, Inc. She is responsible for day-to-day operations, strategic and marketing planning, competition and market analysis, direct contact with established customer base, designed to retain and improve the business relationship and direct personal contact with new customers prospect. From 1990-1992 Mrs. Shtarkman was a Chemist at Biological Environmental Control Laboratories, Inc. Mrs. Shtarkman received her Bachelor of Science degree from Ukrainian Institute of Technology, Kiev, Ukraine in 1977, had special training in American Analytical Training Center in 1990, and completed Business Administration classes in Cuyahoga Community College in 1992.
An alumni of the New York University, Dr. Sino has over 25 years of executive health care experience. His credentials include positions as the Vice President of Beth Israel Medical Center in Manhattan, Chief Operating Officer of New York Doctors MSO, Vice President of Coney Island Hospital/New York City Health and Hospitals Corporation and others. Currently Dr. Sino is the CEO/President of Faith Health Care, Inc. which is a Multi-Disease Management and Transitional Care Company serving Miami-Dade, Monroe, Broward, Palm Beach, Pt. St. Lucie, Martin and Indian River counties in Florida. Dr. Sino is on the Board of Advisers of Alliance for Aging and CMS District IV (Miami-Dade). He has received several professional Awards including NAPH Award for Quality, Health Association of New York (HANYS) Award and 3 New York City Cameo Awards.
Jim Puffenberger has over 29 years of experience in the medical device, medical imaging, and pharmaceutical industries. He holds the position of Senior Vice President of Sales and Marketing and is responsible for developing worldwide commercial markets. Early in his career, Mr. Puffenberger held various sales and marketing positions with Johnson & Johnson and with Baxter International (Dialysis Division). For nearly sixteen years he led various business units within Advanced Technology Laboratories (ATL), a Seattle based, leading manufacturer of diagnostic medical imaging equipment, now wholly owned by Philips Electronics. While with ATL/Philips, Mr. Puffenberger served as the Vice President of Sales for a $120 million business unit and successfully designed its integration into the Philips organization. He had added responsibility for developing the sales, marketing, and distribution activities of Philips Canada and created strategies for its new product introduction. Mr. Puffenberger was twice recognized as the manager of the year, among other honors, with ATL and Philips in North America and has acted in an advisory role for various medical device companies and as President of a start-up medical device company. Mr. Puffenberger holds a degree in Zoology and Chemistry from Miami University in Oxford, Ohio and an MBA with Distinction from Tiffin University. He resides in Bratenahl, Ohio.
Ms. Kristen Karohl did join Dialysa in March, 2013
Her experience included a research technician in cardiovascular medicine in Cleveland Clinic.
She has experience to run various experiments-measuring for specific proteins in failing and non failing human heart tissue.
She holds position as a Laboratory Director. Ms. Karohl is responsible for day to day management of the laboratory utilizing her knowledge and experience in microbiological testing and data analysis.
Ms. Karohl received her Bachelor of Science in Biology with minor in Chemistry and Psychology from Bowling Green State University.